GlassScriptPhysician profile
Robert B Peel
NPI 1285741470
$2,946.77
in general payments reported to CMS, 2019-2025
18 companies · $588 in 2025
The $588 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2020: $31.51 · 2021: $179 · 2022: $559 · 2023: $689 · 2024: $483 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,760.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $847.01 | 2019-2024 | Puraply, Apligraf |
| Paratek Pharmaceuticals, INC. | $390.05 | 2021-2024 | Nuzyra |
| Treace Medical Concepts, INC. | $263.98 | 2022-2025 | |
| Medtronic, INC. | $189.51 | 2022-2024 | Intellis Adaptivestim |
| Kerecis Limited | $182.16 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Stryker Corporation | $151.59 | 2019 | |
| Aroa Biosurgery Incorporated | $149.20 | 2025 | |
| Paragon 28, INC. | $141.97 | 2023-2025 | Portfolio, Phantom Metatarsal Shortening |
| Smith+Nephew, INC. | $137.88 | 2019-2022 | |
| Tactile Systems Technology INC | $122.26 | 2024 | Flexitouch Plus, Entre Plus |
| Grt US Holding, INC. | $116.42 | 2022 | |
| Bioventus LLC | $115.42 | 2019 | |
| Zyla Life Sciences, INC. | $46.98 | 2019-2020 | |
| Nevro Corp. | $20.65 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $19.93 | 2023 | Seglentis |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $18.85 | 2023 | |
| Advanced Oxygen Therapy INC. | $17.92 | 2022 | |
| Horizon Therapeutics Plc | $14.99 | 2023 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Peel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.